menu
    • menu

    Company profile for Novel Laboratories, Inc.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in December of 2006 by industry veteran, Dr. Veerappan Subramanian, Novel Laboratories, Inc. is a full-service pharmaceutical company that develops, manufactures, markets and distributes difficult to develop, technology-driven specialty generics for the US and European markets. With its core competencies in generics, Novel has also filed for multiple new products with the FDA and is anxiously awaiting approval. The Co...
    Founded in December of 2006 by industry veteran, Dr. Veerappan Subramanian, Novel Laboratories, Inc. is a full-service pharmaceutical company that develops, manufactures, markets and distributes difficult to develop, technology-driven specialty generics for the US and European markets. With its core competencies in generics, Novel has also filed for multiple new products with the FDA and is anxiously awaiting approval. The Company grows the majority of its products in-house in addition to partnering with pharmaceuticals worldwide to synergize development, manufacturing, and marketing capabilities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Novel Laboratories, Inc.United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Campus Drive, Somerset, NJ 08873 
    Telephone
    Telephone
    (908) 603-6000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.novellabs.net/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novel Labs' Generic Fluocinolone Acetonide Receives Approval in the U.S.
    Novel Labs' Generic Fluocinolone Acetonide Receives Approval in the U.S.

    07 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207347

    FDA
    07 Aug 2023
    Share Share
    FDA issue form 483 to Novel Laboratories Inc. d.b.a. Lupin Somerset
    FDA issue form 483 to Novel Laboratories Inc. d.b.a. Lupin Somerset

    17 May 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-issue-form-483-to-novel-laboratories-inc-dba-lupin-somerset-1652849037.pdf

    FDA
    17 May 2022
    Share Share
    Enforcement Report - Week of August 25, 2021
    Enforcement Report - Week of August 25, 2021

    25 Aug 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf

    FDA
    25 Aug 2021
    Share Share
    FDA Issues Form 483 to Novel Laboratories, Inc. d.b.a LUPIN
    FDA Issues Form 483 to Novel Laboratories, Inc. d.b.a LUPIN

    14 Jan 2021

    // FDA

    https://www.fda.gov/media/145108/download

    FDA
    14 Jan 2021
    Share Share
    Enforcement Report - Week of January 9, 2019
    Enforcement Report - Week of January 9, 2019

    09 Jan 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-9-2019-1547012578.pdf

    FDA
    09 Jan 2019
    Share Share
    Valsartan products not currently recalled - Updated November 27, 2018
    Valsartan products not currently recalled - Updated November 27, 2018

    28 Nov 2018

    // FDA

    https://www.fda.gov/downloads/Drugs/DrugSafety/UCM615704.pdf

    FDA
    28 Nov 2018
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2024-05-17

    Novel Laboratories, Inc.

    City : Somerset

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8873

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2024-05-17

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2023-01-13

    Novel Laboratories, Inc.

    City : Somerset

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8873

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2023-01-13

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2022-03-30

    Novel Laboratories, Inc.

    City : Somerset

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8873

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2022-03-30

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Official Action Indicated

    Inspection End Date : 2020-11-05

    Novel Laboratories, Inc.

    City : Somerset

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8873

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Official Action Indicated

    Inspection End Date : 2020-11-05

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-11-08

    Novel Laboratories, Inc.

    City : Somerset

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8873

    District :

    Center :

    Project Area : Bioresearch Monitoring

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-11-08

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-02-23

    Novel Laboratories, Inc.

    City : Somerset

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8873

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-02-23

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-08-08

    Novel Laboratories, Inc.

    City : Somerset

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8873

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-08-08

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2017-02-14

    Novel Laboratories, Inc.

    City : Somerset

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8873

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2017-02-14

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-11-17

    Novel Laboratories, Inc.

    City : Somerset

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8873

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2015-11-17

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    10

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-01-22

    Novel Laboratories, Inc.

    City : Somerset

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8873

    District :

    Center :

    Project Area : Bioresearch Monitoring

    District Decision : No Action Indicated

    Inspection End Date : 2015-01-22

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search